The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Initiation of targeted therapy based on ctDNA only in metastatic NSCLC.
 
Jean Gabriel Bustamante Alvarez
No Relationships to Disclose
 
Kristin Dittmar
No Relationships to Disclose
 
Sarah A Janse
No Relationships to Disclose
 
Stephanie Kiourtsis
No Relationships to Disclose
 
Dwight Hall Owen
Consulting or Advisory Role - AstraZeneca; L&M Policy Research
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Merck Sharp & Dohme (Inst); Palobiofarma (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Erin Marie Bertino
Consulting or Advisory Role - Boehringer Ingelheim; Takeda
 
Kai He
Honoraria - Geneplus
Consulting or Advisory Role - Perthera
Research Funding - Adaptimmune (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Mirati Therapeutics (Inst)
 
David Paul Carbone
Employment - James Cancer Center
Honoraria - AstraZeneca; Nexus Pharmaceuticals Inc
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Biothera; Boehringer Ingelheim; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; Genentech/Roche; Helsinn Therapeutics; Incyte; Inivata; Loxo; Merck; Novartis; Peregrine Pharmaceuticals; Pfizer; Synta; Synta
Research Funding - Bristol-Myers Squibb
 
Gregory Alan Otterson
Consulting or Advisory Role - Novartis (Inst); Novocure (Inst); Takeda (Inst)
Research Funding - Acerta Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); Ignyta (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)